Literature DB >> 20852902

Running wheel activity restores MPTP-induced functional deficits.

Anders Fredriksson1, Ingels Maria Stigsdotter, Anders Hurtig, Béatrice Ewalds-Kvist, Trevor Archer.   

Abstract

Wheel-running and treadmill running physical exercise have been shown to alleviate parkinsonism in both laboratory and clinical studies. MPTP was administered to C57/BL6 mice using two different procedures: (a) administration of a double-dose regime (MPTP 2 × 20 or 2 × 40 mg/kg, separated by a 24-h interval), vehicle (saline 5 ml/kg) or saline (vehicle 2 × 5 ml/kg), and (b) administration of a single-dose weekly regime (MPTP 1 × 40 mg/kg) or saline (vehicle 1 × 5 ml/kg) repeated over 4 consecutive weeks. For each procedure, two different physical exercise regimes were followed: (a) after the double-dose MPTP regime, mice were given daily 30-min periods of wheel-running exercise over 5 consecutive days/week or placed in a cage in close proximity to the running wheels for 3 weeks. (b) Mice were either given wheel-running activity on 4 consecutive days (30-min periods) or placed in a cage nearby for 14 weeks. Behavioral testing was as follows: (a) after 3 weeks of exercise/no exercise, mice were tested for spontaneous motor activity (60 min) and subthreshold L-Dopa (5 mg/kg)-induced activity. (b) Spontaneous motor activity was measured on the fifth day during each of the each of the first 5 weeks (Tests 1-5), about 1 h before injections (first 4 weeks), and continued on the 5th days of the 6th to the 14th weeks (Tests 6-14). Subthreshold L-Dopa (5 mg/kg)-induced activity was tested on the 6th, 8th, 10th, 12th and 14th weeks. (b) Mice from the single-dose MPTP weekly regime were killed during the 15th week and striatal regions taken for dopamine analysis, whereas frontal and parietal cortex and hippocampus were taken for analysis of brain-derived neurotrophic factor (BDNF). It was shown that in both experiments, i.e., the double-dose regime and single-dose weekly regime of MPTP administration, physical activity attenuated markedly the MPTP-induced akinesia/hypokinesia in both the spontaneous motor activity and restored motor activity completely in subthreshold L-Dopa tests. Running wheel activity attenuated markedly the loss of dopamine due to repeated administrations of MPTP. BDNF protein level in the parietal cortex was elevated by the MPTP insult and increased further by physical exercise. Physical running wheel exercise alleviated both the functional and biomarker expressions of MPTP-induced parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20852902     DOI: 10.1007/s00702-010-0474-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  86 in total

Review 1.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons.

Authors:  Flaubert Tchantchou; Pascale N Lacor; Zhiming Cao; Lixing Lao; Yan Hou; Changhai Cui; William L Klein; Yuan Luo
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

3.  Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF.

Authors:  Ann D Cohen; Jennifer L Tillerson; Amanda D Smith; Timothy Schallert; Michael J Zigmond
Journal:  J Neurochem       Date:  2003-04       Impact factor: 5.372

4.  Exercise therapy for Parkinson's disease.

Authors:  S S Palmer; J A Mortimer; D D Webster; R Bistevins; G L Dickinson
Journal:  Arch Phys Med Rehabil       Date:  1986-10       Impact factor: 3.966

Review 5.  Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.

Authors:  R E Heikkila; B A Sieber; L Manzino; P K Sonsalla
Journal:  Mol Chem Neuropathol       Date:  1989-06

6.  Effects of unpredictable chronic stress on behavior and brain-derived neurotrophic factor expression in CA3 subfield and dentate gyrus of the hippocampus in different aged rats.

Authors:  Ying Li; Yong-juan Ji; Hong Jiang; De-xiang Liu; Qian Zhang; Shu-jian Fan; Fang Pan
Journal:  Chin Med J (Engl)       Date:  2009-07-05       Impact factor: 2.628

7.  Voluntary exercise or amphetamine treatment, but not the combination, increases hippocampal brain-derived neurotrophic factor and synapsin I following cortical contusion injury in rats.

Authors:  G S Griesbach; D A Hovda; F Gomez-Pinilla; R L Sutton
Journal:  Neuroscience       Date:  2008-04-09       Impact factor: 3.590

Review 8.  Exercise: a behavioral intervention to enhance brain health and plasticity.

Authors:  Carl W Cotman; Nicole C Berchtold
Journal:  Trends Neurosci       Date:  2002-06       Impact factor: 13.837

9.  Brain-derived neurotrophic factor controls activity-dependent maturation of CA1 synapses by downregulating tonic activation of presynaptic kainate receptors.

Authors:  Marko Sallert; Tomi Rantamäki; Aino Vesikansa; Heidi Anthoni; Kirsi Harju; Jari Yli-Kauhaluoma; Tomi Taira; Eero Castren; Sari E Lauri
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

10.  The protein dendrite arborization and synapse maturation 1 (Dasm-1) is dispensable for dendrite arborization.

Authors:  Archana Mishra; Boris Knerr; Sónia Paixão; Edgar R Kramer; Rüdiger Klein
Journal:  Mol Cell Biol       Date:  2008-02-11       Impact factor: 4.272

View more
  16 in total

1.  Delayed exercise-induced functional and neurochemical partial restoration following MPTP.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurotox Res       Date:  2011-08-10       Impact factor: 3.911

2.  The yeast product Milmed enhances the effect of physical exercise on motor performance and dopamine neurochemistry recovery in MPTP-lesioned mice.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurotox Res       Date:  2013-07-27       Impact factor: 3.911

Review 3.  Influence of physical exercise on traumatic brain injury deficits: scaffolding effect.

Authors:  Trevor Archer
Journal:  Neurotox Res       Date:  2011-12-20       Impact factor: 3.911

4.  Physical exercise alleviates ADHD symptoms: regional deficits and development trajectory.

Authors:  Trevor Archer; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2011-08-18       Impact factor: 3.911

Review 5.  Lifelong brain health is a lifelong challenge: from evolutionary principles to empirical evidence.

Authors:  Mark P Mattson
Journal:  Ageing Res Rev       Date:  2015-01-07       Impact factor: 10.895

6.  Six weeks of voluntary exercise don't protect C57BL/6 mice against neurotoxicity of MPTP and MPP(+).

Authors:  Aderbal S Aguiar; Fabrine Sales Massafera Tristão; Majid Amar; Caroline Chevarin; Viviane Glaser; Roberta de Paula Martins; Eduardo Luiz Gasnhar Moreira; Raymond Mongeau; Laurence Lanfumey; Rita Raisman-Vozari; Alexandra Latini; Rui D S Prediger
Journal:  Neurotox Res       Date:  2013-07-20       Impact factor: 3.911

7.  Altered cytokine and BDNF levels in autism spectrum disorder.

Authors:  S Ricci; R Businaro; F Ippoliti; V R Lo Vasco; F Massoni; E Onofri; G M Troili; V Pontecorvi; M Morelli; M Rapp Ricciardi; T Archer
Journal:  Neurotox Res       Date:  2013-04-19       Impact factor: 3.911

8.  Investigate the chronic neurotoxic effects of diquat.

Authors:  Senthilkumar S Karuppagounder; Manuj Ahuja; Manal Buabeid; Koodeswaran Parameshwaran; Engy Abdel-Rehman; Vishnu Suppiramaniam; Muralikrishanan Dhanasekaran
Journal:  Neurochem Res       Date:  2012-02-14       Impact factor: 3.996

9.  Positive affect and age as predictors of exercise compliance.

Authors:  Danilo Garcia; Trevor Archer
Journal:  PeerJ       Date:  2014-12-16       Impact factor: 2.984

10.  Effects of using the nintendo wii fit plus platform in the sensorimotor training of gait disorders in Parkinson's disease.

Authors:  Giovanna Barros Gonçalves; Marco Antônio A Leite; Marco Orsini; João Santos Pereira
Journal:  Neurol Int       Date:  2014-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.